Efficacy of Definitive Radiotherapy for Patients with Clinical Stage IIIB or IIIC Lung Adenocarcinoma and Epidermal Growth Factor Receptor (EGFR) Mutations Treated Using First- or Second-Generation EGFR Tyrosine Kinase Inhibitors.

Tu, Chih-Yen; Hsia, Te-Chun; Lin, Ying-Chun; Liang, Ji-An; Li, Chia-Chin; Chien, Chun-Ru

Tu, Chih-Yen; Hsia, Te-Chun; Lin, Ying-Chun; Liang, Ji-An; Li, Chia-Chin; Chien, Chun-Ru.

Afiliação

Tu CY; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Hsia TC; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Lin YC; Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Liang JA; Health Science and Industry, College of Health Care, China Medical University, Taichung, Taiwan.
Li CC; School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan.
Chien CR; Department of Radiation Oncology, China Medical University Hospital, Taichung, Taiwan.

Can Respir J ; 2024: 8889536, 2024.

Article em En | MEDLINE | ID: mdl-38476120

Assuntos

Adenocarcinoma de Pulmão; Neoplasias Pulmonares; Adulto; Humanos; Estudos Retrospectivos; Inibidores de Proteínas Quinases/uso terapêutico; Resultado do Tratamento; Adenocarcinoma de Pulmão/patologia; Neoplasias Pulmonares/patologia; Receptores ErbB/genética; Receptores ErbB/uso terapêutico; Mutação

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Adenocarcinoma de Pulmão / Neoplasias Pulmonares Idioma: En Revista: Can Respir J Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google